Not always, but probably yes on at least one type of test. Syphilis screening involves two different categories of blood tests, and they behave very differently after successful treatment. One type typically stays positive for life. The other usually drops to low levels or becomes negative, but even that isn’t guaranteed. Understanding which test does what will help you make sense of your results.
Two Types of Syphilis Tests, Two Different Outcomes
Syphilis blood work falls into two categories: treponemal tests and non-treponemal tests. They measure different things, and that’s why they give different results after treatment.
Treponemal tests (the most common are FTA-ABS, TPPA, and rapid immunoassays) detect antibodies your immune system made specifically against the syphilis bacterium. These antibodies persist in about 85% of treated patients for life. A 2024 CDC laboratory guidance document states plainly that treponemal antibodies “typically persist for life despite treatment” and cannot distinguish between a current infection and one that was successfully treated years ago. The only exception is people treated very early in primary syphilis: roughly 15% to 25% of them will eventually test negative on treponemal tests within two to three years. If you were treated during secondary syphilis or later, studies have found no cases of the treponemal test reverting to negative.
Non-treponemal tests (RPR and VDRL) measure a different type of antibody, one your body produces in response to cellular damage caused by the infection. Because these antibodies aren’t directed at the bacterium itself, they tend to fade once the infection is cleared. After successful treatment, your RPR or VDRL titer is expected to drop at least fourfold. For primary or secondary syphilis, that drop should happen within 6 to 12 months. For latent syphilis, the window is 12 to 24 months. In many people, non-treponemal tests eventually become completely negative.
What “Serofast” Means
Some people’s non-treponemal test never fully drops to zero, and it doesn’t fall by the expected fourfold either. This is called a serofast state. It affects roughly 15% to 20% of treated patients, though estimates range from 5% to as high as 41% depending on the population studied. If you’re serofast, your RPR or VDRL stays at a persistently low but stable titer (often 1:1 or 1:2) even though the infection has been cured and you have no symptoms.
Being serofast doesn’t mean treatment failed. The CDC defines it as an insufficient titer decline after the expected timeframe, combined with resolution of any symptoms. It can, however, create confusion at future screenings. A new provider who sees a reactive RPR might not know whether that low titer represents old, treated syphilis or something new. This is one reason keeping records of your past test results and treatment dates matters.
Factors That Slow the Titer Drop
How quickly your non-treponemal titer falls depends on several things. A large retrospective study at an HIV referral hospital in Tokyo identified three factors independently linked to a slower decline in RPR after treatment: older age, a history of previous syphilis episodes, and a lower RPR titer at the time treatment began. Each of these made the month-to-month decrease in titer smaller.
Having had syphilis before is especially relevant. If your immune system has already encountered the bacterium, your antibody response the second time around may behave differently, and titers tend to be more stubborn about falling. A lower starting titer also leaves less room to demonstrate the expected fourfold drop, which can make it harder to confirm successful treatment on paper even when the infection is actually gone.
HIV status was initially suspected to play a role, but the same study found that the apparent association was likely explained by the fact that HIV-positive patients in the cohort tended to be older and more likely to have had previous syphilis infections.
How Follow-Up Testing Works
After treatment for primary or secondary syphilis, the CDC recommends clinical and serologic evaluation at 6 and 12 months. For latent syphilis, the monitoring window extends to 24 months. Your provider will track your non-treponemal titer over time, looking for that fourfold decline. A titer of 1:32 dropping to 1:8, for example, counts as a fourfold (two-dilution) decrease.
If instead of declining, your titer rises fourfold or more after treatment, that’s a red flag for either reinfection or treatment failure. A confirmed fourfold increase triggers further evaluation, including testing for HIV and possible examination of spinal fluid to check for neurosyphilis, followed by additional antibiotic treatment.
Patients with persistently low but stable titers after treatment are generally considered successfully treated. The key distinction is between a titer that’s low and holding steady (serofast, likely fine) and one that’s climbing (needs attention).
What This Means for Future Screening
If you’ve been treated for syphilis, you should expect that future syphilis screenings may come back positive, at least on one test. Many labs now use a “reverse sequence” screening algorithm, where a treponemal test is run first. Since that test stays positive for life in most people, you’ll likely trigger a reactive result every time you’re screened. The lab will then run a non-treponemal test (RPR or VDRL) to determine whether the result reflects active infection or old, treated disease.
If your non-treponemal test is nonreactive or shows a low, stable titer consistent with your history, no further treatment is needed. But this process can cause anxiety, especially if the provider ordering the test isn’t aware of your history. Keeping a personal record of your diagnosis date, treatment, and your most recent RPR titer gives any new provider the context they need to interpret results correctly.
For the roughly 15% to 25% of people treated during early primary syphilis whose treponemal test eventually reverts to negative, future screenings may come back entirely clean. But this is the exception, not the rule. For most people, a past syphilis infection leaves a permanent serologic footprint, one that reflects your immune system’s memory of the infection rather than any ongoing disease.